Serial plotting of symphysis-fundal height and estimated fetal weight to improve the antenatal detection of infants small for gestational age: A cluster randomised trial.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
06 2023
Historique:
revised: 09 11 2022
received: 25 07 2022
accepted: 21 11 2022
medline: 9 5 2023
pubmed: 20 1 2023
entrez: 19 1 2023
Statut: ppublish

Résumé

To assess whether standardised longitudinal reporting of growth monitoring information improves antenatal detection of infants who are small for gestational age (SGA), compared with usual care. Cluster-randomised controlled trial. Sixteen French level-3 units in 2018-2019. Singleton pregnancies. The intervention consisted of the serial plotting of symphysis-fundal height (SFH) and estimated fetal weight (EFW) measurements on customised growth charts using a software program, compared with standard antenatal care. We estimated relative risks (RR) adjusted for known risk factors for fetal growth restriction (FGR). The primary outcome was antenatal detection of FGR among SGA births (with birthweights below the tenth centile of French customised curves), defined as the mention of suspected FGR in medical records and either referral ultrasounds for growth monitoring or indicated delivery for FGR. Secondary outcomes were false-positive rates, mode of delivery, perinatal morbidity and mortality, and number of antenatal visits and ultrasounds. In total, seven intervention clusters (n = 4349) and eight control clusters (n = 4943) were analysed, after the exclusion of one intervention centre for a major deviation in protocol. SGA births represented 613 (14.1%) and 626 (12.7%) of all births, respectively. The rates of antenatal detection of FGR among SGA births were 40.0% in the intervention arm versus 37.1% in the control arm (crude RR 1.08, 95% CI 0.87-1.34; adj RR 1.09, 95% CI 0.88-1.35). No benefits of the intervention were detected in the analyses of secondary outcomes. Serial plotting of SFH and EFW measurements on customised growth charts did not improve the antenatal detection of FGR among SGA births.

Identifiants

pubmed: 36655486
doi: 10.1111/1471-0528.17399
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

729-739

Subventions

Organisme : Ministère des Affaires Sociales et de la Santé - National Program for Hospital Clinical Research
ID : PHRC-N-14-0442

Investigateurs

Tiphaine Barjat (T)
Florence Bretelle (F)
Véronique Debarge (V)
Gilles Grangé (G)
Benoist Guillaume (B)
Hélène Heckenroth (H)
Pascale Hoffmann (P)
Laurent Mandelbrot (L)
Franck Perrotin (F)
Patrick Rozenberg (P)
Nicolas Sananes (N)
Thomas Schmitz (T)
Marie-Victoire Sénat (MV)
Loïc Sentilhes (L)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.

Références

Royal College of Obstetricians and Gynaecologists. The investigation and management of the small-for-gestational-age fetus. Guideline no. 31. London: RCOG; 2002.
French College of Gynecologists Obstetricians. Intra-uterine growth retardation: guidelines for clinical practice-short text. J Gynecol Obstet Biol Reprod (Paris). 2013;42(8):1018-25.
McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med. 1999;340(16):1234-8.
Ego A, Monier I, Skaare K, Zeitlin J. Antenatal detection of fetal growth restriction and risk of stillbirth: population-based case-control study. Ultrasound Obstet Gynecol. 2020;55(5):613-20.
Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ. 2013;346:f108.
Lindqvist PG, Molin J. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol. 2005;25(3):258-64.
Stacey T, Thompson JM, Mitchell EA, Zuccollo JM, Ekeroma AJ, McCowan LM. Antenatal care, identification of suboptimal fetal growth and risk of late stillbirth: findings from the Auckland Stillbirth Study. Aust N Z J Obstet Gynaecol. 2012;52(3):242-7.
Evers AC, Nikkels PG, Brouwers HA, Boon J, van Egmond-Linden A, Hart C, et al. Substandard care in antepartum term stillbirths: prospective cohort study. Acta Obstet Gynecol Scand. 2011;90(12):1416-22.
Richardus JH, Graafmans WC, Verloove-Vanhorick SP, Mackenbach JP, EuroNatal International Audit Panel, EuroNatal Working Group. Differences in perinatal mortality and suboptimal care between 10 European regions: results of an international audit. BJOG. 2003;110(2):97-105.
Institute of Obstetricians and Gynecologists Royal College of Physicians of Ireland. Fetal growth restriction, recognition, diagnosis & management. Clinical practice guideline no. 28. Version 1.1. 2017. [cited 2017 September 10]. Available at: http://www.hse.ie/eng/services/publications/Clinical-Strategy-and-Programmes/Fetal-Growth-Restriction.pdf
New Zealand Maternal Fetal Medicine Network. Guideline for the management of suspected small for gestational age singleton pregnancies after 34wk' gestation. New Zealand Maternal Fetal Medicine Network; 2014.
American College of Obstetricians and Gynecologists. Fetal growth restriction. Washington, DC: ACOG; 2000.
Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP. Effectiveness of detection of intrauterine growth retardation by abdominal palpation as screening test in a low risk population: an observational study. Eur J Obstet Gynecol Reprod Biol. 2004;116(2):164-9.
Chauhan SP, Hendrix NW, Magann EF, Morrison JC, Kenney SP, Devoe LD. Limitations of clinical and sonographic estimates of birth weight: experience with 1034 parturients. Obstet Gynecol. 1998;91(1):72-7.
Fratelli N, Valcamonico A, Prefumo F, Pagani G, Guarneri T, Frusca T. Effects of antenatal recognition and follow-up on perinatal outcomes in small-for-gestational age infants delivered after 36 weeks. Acta Obstet Gynecol Scand. 2013;92(2):223-9.
Jahn A, Razum O, Berle P. Routine screening for intrauterine growth retardation in Germany: low sensitivity and questionable benefit for diagnosed cases. Acta Obstet Gynecol Scand. 1998;77(6):643-8.
Mattioli KP, Sanderson M, Chauhan SP. Inadequate identification of small-for-gestational-age fetuses at an urban teaching hospital. Int J Gynaecol Obstet. 2010;109(2):140-3.
Monier I, Blondel B, Ego A, Kaminiski M, Goffinet F, Zeitlin J. Poor effectiveness of antenatal detection of fetal growth restriction and consequences for obstetric management and neonatal outcomes: a French national study. BJOG. 2015;122(4):518-27.
Verlijsdonk JW, Winkens B, Boers K, Scherjon S, Roumen F. Suspected versus non-suspected small-for-gestational age fetuses at term: perinatal outcomes. J Matern Fetal Neonatal Med. 2012;25(7):938-43.
Vieira MC, Relph S, Muruet-Gutierrez W, Elstad M, Coker B, Moitt N, et al. Evaluation of the growth assessment protocol (GAP) for antenatal detection of small for gestational age: the DESiGN cluster randomised trial. PLoS Med. 2022;19(6):e1004004.
Petersen J, Jahn A. Suspicious findings in antenatal care and their implications from the mothers' perspective: a prospective study in Germany. Birth. 2008;35(1):41-9.
Triunfo S. A lesson from behavioral economics for reducing obstetric interventions-placing more weight on perceived gains vs perceived losses. JAMA Netw Open. 2022;5(3):e222181.
Chamagne M, Beffara F, Patte C, Vigouroux C, Renevier B. Management of fetal growth restriction in France: survey of teaching hospitals and tertiary referral centers. Gynecol Obstet Fertil Senol. 2021;49(10):756-62.
Gibbons K, Beckmann M, Flenady V, Rossouw D, Gardener G, Mahomed K, et al. A survey of policies for the monitoring of fetal growth in Australian and New Zealand hospitals. Aust N Z J Obstet Gynaecol. 2011;51(6):493-8.
Morse K, Williams A, Gardosi J. Fetal growth screening by fundal height measurement. Best Pract Res Clin Obstet Gynaecol. 2009;23(6):809-18.
Heude B, Le Guern M, Forhan A, Scherdel P, Kadawathagedara M, Dufourg MN, et al. Are selection criteria for healthy pregnancies responsible for the gap between fetal growth in the French national Elfe birth cohort and the intergrowth-21st fetal growth standards? Paediatr Perinat Epidemiol. 2019;33(1):47-56.
Gardosi J, Francis A. Controlled trial of fundal height measurement plotted on customised antenatal growth charts. Br J Obstet Gynaecol. 1999;106(4):309-17.
Roex A, Nikpoor P, van Eerd E, Hodyl N, Dekker G. Serial plotting on customised fundal height charts results in doubling of the antenatal detection of small for gestational age fetuses in nulliparous women. Aust N Z J Obstet Gynaecol. 2012;52(1):78-82.
Campbell MK, Piaggio G, Elbourne DR, Altman DG, CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661.
Carbonne B, Sentilhes L, Vayssiere C. Intra uterine growth retardation: guidelines for clinical practice-introduction. J Gynecol Obstet Biol Reprod (Paris). 2013;42(8):868-9.
Vayssière C, Sentilhes L, Ego A, Bernard C, Cambourieu D, Flamant C, et al. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol. 2015;193:10-8.
Grange G. Screening and diagnosis of small for gestational age fetuses. J Gynecol Obstet Biol Reprod (Paris). 2013;42(8):921-8.
Fournie A, Lefebvre-Lacoeuille C, Cotici V, Harif M, Descamps P. The fundal height measurements in single pregnancies and the detection of fetal growth retardation. J Gynecol Obstet Biol Reprod (Paris). 2007;36(7):625-30.
Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet. 1992;339(8788):283-7.
Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol. 1995;6(3):168-74.
Ego A, Prunet C, Lebreton E, Blondel B, Kaminski M, Goffinet F, et al. Customized and non-customized French intrauterine growth curves. I - Methodology. J Gynecol Obstet Biol Reprod (Paris). 2016;45(2):155-64.
Kayem G, Grange G, Breart G, Goffinet F. Comparison of fundal height measurement and sonographically measured fetal abdominal circumference in the prediction of high and low birth weight at term. Ultrasound Obstet Gynecol. 2009;34(5):566-71.
Mongelli M, Gardosi J. Symphysis-fundus height and pregnancy characteristics in ultrasound-dated pregnancies. Obstet Gynecol. 1999;94(4):591-4.
Donner A, Klar N. Design and analysis of cluster ransomised trials in health research. London: Arnold; 2000.
Haute Autorité de Santé. Suivi et orientation des femmes enceintes en fonction des situations à risque identifiées. Recommandations professionnelles. 2007 [cited 2013 June 20]. Available at: https://www.has-sante.fr/jcms/c_547976/fr/suivi-et-orientation-des-femmes-enceintes-en-fonction-des-situations-a-risque-identifiees
Monier I, Blondel B, Ego A, Kaminski M, Goffinet F, Zeitlin J. Does the presence of risk factors for fetal growth restriction increase the probability of antenatal detection? A French National Study. Paediatr Perinat Epidemiol. 2016;30(1):46-55.
McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940-3.
White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48:817-38.
Reboul Q, Delabaere A, Luo ZC, Nuyt AM, Wu Y, Chauleur C, et al. Prediction of small-for-gestational-age neonate by third-trimester fetal biometry and impact of ultrasound-delivery interval. Ultrasound Obstet Gynecol. 2017;49(3):372-8.
Ciobanu A, Anthoulakis C, Syngelaki A, Akolekar R, Nicolaides KH. Prediction of small-for-gestational-age neonates at 35-37 weeks' gestation: contribution of maternal factors and growth velocity between 32 and 36 weeks. Ultrasound Obstet Gynecol. 2019;53(5):630-7.
Pay AS, Wiik J, Backe B, Jacobsson B, Strandell A, Klovning A. Symphysis-fundus height measurement to predict small-for-gestational-age status at birth: a systematic review. BMC Pregnancy Childbirth. 2015;15:22.
Goto E. Prediction of low birthweight and small for gestational age from symphysis-fundal height mainly in developing countries: a meta-analysis. J Epidemiol Community Health. 2013;67(12):999-1005.
Lindhard A, Nielsen PV, Mouritsen LA, Zachariassen A, Sørensen HU, Rosenø H. The implications of introducing the symphyseal-fundal height-measurement. A prospective randomized controlled trial. Br J Obstet Gynaecol. 1990;97(8):675-80.
Robert Peter J, Ho JJ, Valliapan J, Sivasangari S. Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth. Cochrane Database Syst Rev. 2015;2015(9):CD008136.
Henrichs J, Verfaille V, Jellema P, Viester L, Pajkrt E, Wilschut J, et al. Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial. BMJ. 2019;367:l5517.
Roma E, Arnau A, Berdala R, Bergos C, Montesinos J, Figueras F. Ultrasound screening for fetal growth restriction at 36 vs 32 weeks' gestation: a randomized trial (ROUTE). Ultrasound Obstet Gynecol. 2015;46(4):391-7.
Wanyonyi SZ, Orwa J, Ozelle H, Martinez J, Atsali E, Vinayak S, et al. Routine third-trimester ultrasound for the detection of small-for-gestational age in low-risk pregnancies (ROTTUS study): randomized controlled trial. Ultrasound Obstet Gynecol. 2021;57(6):910-6.
Ashimi Balogun O, Sibai BM, Pedroza C, Blackwell SC, Barrett TL, Chauhan SP. Serial third-trimester ultrasonography compared with routine care in uncomplicated pregnancies: a randomized controlled trial. Obstet Gynecol. 2018;132(6):1358-67.
Sovio U, White IR, Dacey A, Pasupathy D, Smith GCS. Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the pregnancy outcome prediction (POP) study: a prospective cohort study. Lancet. 2015;386(10008):2089-97.
Gardosi J, Giddings S, Clifford S, Wood L, Francis A. Association between reduced stillbirth rates in England and regional uptake of accreditation training in customised fetal growth assessment. BMJ Open. 2013;3(12):e003942.
Iliodromiti S, Smith GCS, Lawlor DA, Pell JP, Nelson SM. UK stillbirth trends in over 11 million births provide no evidence to support effectiveness of growth assessment protocol program. Ultrasound Obstet Gynecol. 2020;55(5):599-604.
Michaeli J, Michaeli O, Rozitzky A, Grisaru-Granovsky S, Feldman N, Srebnik N. Application of prospect theory in obstetrics by evaluating mode of delivery and outcomes in neonates born small or appropriate for gestational age. JAMA Netw Open. 2022;5(3):e222177.
Leite DFB, Cecatti JG. Fetal growth restriction prediction: how to move beyond. ScientificWorldJournal. 2019;2019:1519048.
Allotey J, Thangaratinam S. Prognostic models need to look beyond fetal size. BJOG. 2019;126(4):485.
Iwama N, Obara T, Ishikuro M, Murakami K, Ueno F, Noda A, et al. Risk scores for predicting small for gestational age infants in Japan: the TMM birthree cohort study. Sci Rep. 2022;12(1):8921.
Meertens L, Smits L, van Kuijk S, Aardenburg R, van Dooren I, Langenveld J, et al. External validation and clinical usefulness of first-trimester prediction models for small- and large-for-gestational-age infants: a prospective cohort study. BJOG. 2019;126(4):472-84.

Auteurs

Anne Ego (A)

CNRS, TIMC UMR5525, MESP, Univ. Grenoble Alpes, Department of Public Health, CHU Grenoble Alpes, Grenoble, France.
Univ. Grenoble Alpes, Inserm CIC1406, CHU Grenoble Alpes, Grenoble, France.

Isabelle Monier (I)

Université Paris Cité, Centre of Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), Institut national de la santé et de la recherche médicale (INSERM), Institut national de la recherche agronomique (INRA), Paris, France.
Department of Obstetrics and Gynecology, Antoine Béclère Hospital, AP-HP, Paris Saclay University, Clamart, France.

Antoine Vilotitch (A)

Univ. Grenoble Alpes, Inserm CIC1406, CHU Grenoble Alpes, Grenoble, France.

Gilles Kayem (G)

Université Paris Cité, Centre of Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), Institut national de la santé et de la recherche médicale (INSERM), Institut national de la recherche agronomique (INRA), Paris, France.
Department of Obstetrics and Gynecology, Trousseau Hospital, AP-HP, FHU PREMA, Sorbonne University, Paris, France.

Christophe Vayssiere (C)

Department of Obstetrics and Gynecology, Paule de Viguier Hospital, CHU Toulouse, Toulouse, France.
UMR1295 CERPOP (Centre for Epidemiology and Population Health Research), Team SPHERE (Study of Perinatal, Paediatric and Adolescent Health: Epidemiological Research and Evaluation), Toulouse III University, Toulouse, France.

Eric Verspyck (E)

Department of Obstetrics and Gynecology, Rouen University Hospital, Rouen, France.

Jennifer Zeitlin (J)

Université Paris Cité, Centre of Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), Institut national de la santé et de la recherche médicale (INSERM), Institut national de la recherche agronomique (INRA), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH